TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.
